جست‌وجوی استاد و پژوهشگر

Birgitte Schantz Laursenمشاهده پروفایل

دانشیار

• Medication Therapy Management
• Sexual Health Nursing
• Oncology Nursing
• +۴ مورد دیگر

Birgitte Schantz Laursen is an Associate Professor at Aalborg University Hospital's Department of Clinical Medicine, affiliated with The Faculty of Medicine. She holds dual roles in the Center for Sexology Research and The Clinical Nursing Research Unit. Her work bridges clinical practice and academic research, focusing on sexual health across diverse patient populations. Education background includes a Cand.cur. (Master of Science in Nursing) degree. Research interests center on sexual dysfunction in oncology patients, geriatric nursing, medication management for multi-morbid elderly, and nurse-led sexological interventions. Recent studies address colorectal cancer treatment impacts on sexual health and regenerative therapies for Peyronie's disease. Publications (198+ works) reflect strong contributions to nursing science and clinical medicine. Media engagements (32+ items) highlight public dissemination of research on topics like late sexual debut in adults and chronic disease-related sexual challenges. Supervised 6 PhD candidates focusing on healthcare quality improvement and patient-centered care methodologies. Active in academic networks through conference organization and external teaching activities. Labs/Teams: Core member of Center for Sexology Research and Clinical Nursing Research Unit conducting translational studies from ethnographic fieldwork to clinical trials.

• Oncology
• Cancer Survivorship
• Clinical Research
• +۳ مورد دیگر

Susanne Oksbjerg Dalton is a Professor in the Department of Clinical Medicine at the University of Copenhagen, specializing in Clinical Oncology. Her research focuses on cancer survivorship, symptom management, and quality of life issues for cancer patients. She maintains an active research profile with 174 total research outputs documented in the institutional repository. Her primary research interests include: Cancer survivorship and functional health in aging populations Symptom management (fatigue, pain, insomnia) Clinical trials methodology Socioeconomic factors in cancer outcomes Rehabilitation following cancer treatments Analysis of her recent publications reveals a strong emphasis on population-based studies examining the long-term effects of cancer treatments, with particular attention to quality of life metrics and symptom burden in cancer survivors. Her work frequently utilizes Danish registry data to examine large patient populations. Her research collaborations span multiple institutions and clinical specialties, demonstrating interdisciplinary approach to cancer care research.

Jakob Mortensenمشاهده پروفایل

استادیار

• Epidemiology
• Biostatistics
• Biodemography
• +۴ مورد دیگر

Jakob Mortensen is an Assistant Professor at the Institute of Public Health, University of Southern Denmark, specializing in Epidemiology, Biostatistics, and Biodemography (EBB). His research focuses on heritability, genetic epidemiology, and aging-related health metrics. Education: PhD in Mathematics (1996), MSc in Mathematics with Chemistry (1994), and Pedagogical Teacher Training (1997). Mortensen’s work spans diverse areas such as heritability of chronic diseases (diverticular disease, hand eczema), biomarkers in Crohn’s disease, and grip strength aging patterns. His methodological expertise includes statistical modeling and twin studies. Recent research includes clinical trials on erectile dysfunction therapies post-prostatectomy and studies on intestinal wound healing markers. His publications reflect interdisciplinary collaboration across epidemiology, genetics, and clinical medicine. He contributed to the LLFS (Long Life Study), a family-based research project (2006–2025) exploring genetics and healthy aging.

• Cancer Research
• Pharmacology
• Epidemiology
• +۴ مورد دیگر

Christian Dehlendorff serves as a Part-time Lecturer in the Department of Pharmacy at the University of Copenhagen. His academic work spans cancer research, pharmacology, and epidemiology, with a focus on drug utilization patterns in cancer patients. Dr. Dehlendorff's research interests primarily center on cancer pharmacology and epidemiology. His work examines drug utilization patterns before and after cancer diagnoses, with particular attention to hormonal therapies, NSAIDs, and other pharmaceutical interventions across various cancer types including prostate, breast, testicular, and head and neck cancers. His research employs nationwide cohort studies and randomized clinical trials to investigate treatment outcomes, mortality risks, and biomarker responses in cancer patients. Analysis of his recent publications reveals a strong focus on pharmacoepidemiology in oncology, with particular emphasis on how cancer diagnosis affects medication patterns and how specific drugs impact cancer outcomes. His work frequently utilizes large-scale Danish registry data to conduct population-based studies, demonstrating expertise in both clinical pharmacology and cancer epidemiology. Dr. Dehlendorff collaborates extensively with researchers across oncology specialties, including urological, gynecological, and head and neck cancers. His work often involves multidisciplinary teams comprising oncologists, epidemiologists, and clinical pharmacologists, reflecting the integrative nature of his research at the intersection of pharmacy and cancer care.

• Urology
• Andrology
• Male Reproductive Health
• +۴ مورد دیگر

Jens Otto Reimers Sønksen serves as a Clinical Professor in the Department of Clinical Medicine at the University of Copenhagen, with clinical and research activities centered at Region Hovedstaden's Herlev location (Borgmester Ib Juuls Vej 1) and Copenhagen campus (Blegdamsvej 3). His extensive publication record of 147 outputs demonstrates significant contributions to urological sciences, particularly through collaborative clinical research. His research portfolio spans critical domains in male health: Prostate cancer surgical outcomes and nerve-sparing techniques Testicular cancer risk stratification using microlithiasis markers Cardiovascular comorbidities in erectile dysfunction patients Innovative fertility preservation via stem cell technologies Functional recovery metrics in urological interventions This work consistently bridges clinical practice with translational research, emphasizing evidence-based improvements in patient care. Analysis of his 2024-2025 publications reveals accelerating interdisciplinary collaboration, particularly between urology and cardiology teams investigating shared pathophysiological mechanisms. His research increasingly employs advanced imaging modalities and multi-center trial designs to address complex questions in prostate cancer recovery and male reproductive health. No scientific awards were documented in the available institutional profile. The provided materials contain no information regarding graduate student supervision or specific research grant funding mechanisms. His research operations are embedded within the University of Copenhagen's Department of Clinical Medicine, leveraging hospital-based infrastructure across urology, oncology, and reproductive medicine divisions to facilitate rapid clinical translation of research findings.

• Urology
• Prostate Cancer
• Erectile Dysfunction
• +۳ مورد دیگر

Mikkel Mejlgaard Fode serves as a Clinical Professor at the Department of Clinical Medicine within the Faculty of Health and Medical Sciences at the University of Copenhagen. His clinical work is affiliated with Region Hovedstaden (Capital Region of Denmark), as evidenced by his institutional email domain mikkel.mejlgaard.fode@regionh.dk and physical address at Blegdamsvej 3, Copenhagen N. His research spans urological oncology, sexual medicine, and functional urology, with concentrated expertise in prostate cancer management, erectile dysfunction pathophysiology, and neurogenic bladder disorders. Recent work emphasizes interdisciplinary connections between urology and cardiology/neurology, particularly investigating cardiovascular comorbidities in erectile dysfunction and neuromodulation therapies for multiple sclerosis patients. Analysis of his 2025 publications reveals three dominant research thrusts: (1) surgical outcomes in prostate cancer (robotic prostatectomy, arterial embolization), (2) sexual medicine guideline development through international collaborations like the Fifth International Consultation on Sexual Medicine, and (3) quality-of-life impacts of urological conditions including lymphedema in cancer survivors. His methodology favors prospective cohort designs and multicenter trials. With 80 total research outputs including 53 journal articles and 15 reviews, his work demonstrates consistent leadership in clinical urology research. His active participation in European sexual medicine initiatives and high-volume publication record in journals like BJU International and Andrology underscores significant contributions to the field despite no explicitly listed awards in the source material.

• Urology
• Lower Urinary Tract Disease
• Prostate Cancer
• +۶ مورد دیگر

Peter Zvara is a Professor at the University of Southern Denmark and an Adjunct Professor at the University of Vermont, specializing in Experimental Surgery and Urology. He leads research in lower urinary tract dysfunction, erectile dysfunction, prostate disease, and neuro-urology, with a focus on translational research and animal models. MD and PhD from Comenius University Former head of basic research in functional urology at the University of Vermont (1995–2015) Active collaborator in developing animal models for urological diseases His research spans neuromodulation therapies for overactive bladder, neurogenic bladder dysfunction in multiple sclerosis, and minimally invasive prostate cancer treatments. Key trends include rodent surgery, functional MRI applications, and urodynamic studies. Current activities involve teaching microsurgical techniques and lecturing on benign urology. He supervises students like Patric Clarke and Sunny Hutson.

• Renal Cancer
• Urology
• Erectile Dysfunction
• +۴ مورد دیگر

Lars Lund is a Clinical Professor of Urology at the University of Southern Denmark and a Consultant Urologist at Odense University Hospital. He holds an adjunct professorship at Aalborg University since 2016. His academic career includes leadership roles in the Danish and Nordic renal cancer research communities, such as chairing DaRenCa and NoRenCa. He has extensive clinical experience, including roles as a PhD supervisor for over 14 students and involvement in over 15 clinical trials as a principal investigator. Education includes a DMSci from Aarhus University (2001) and specialized training in urology and surgery. His research focuses on renal cancer, erectile dysfunction, and surgical innovations, with notable contributions to shockwave therapy and cryoablation techniques. He has authored over 230 publications, including peer-reviewed articles, book chapters, and guidelines. Lund’s honors include three best poster awards (2013–2015) and leadership in professional organizations like the Danish Association of Urology. His surgical experimental laboratory has trained numerous surgeons, emphasizing practical skills and simulation-based learning.

• Urology
• Erectile Dysfunction
• Extracorporeal Shockwave Therapy
• +۳ مورد دیگر

Anne Buchhave Olsen is a leading urologist at Aalborg University Hospital, affiliated with the Faculty of Medicine at Aalborg University. Her clinical and research work focuses on urological surgery, infections, and therapeutic innovations. Research Interests: Robotic-assisted prostatectomy (RARP) techniques and cost optimization Extracorporeal shockwave therapy (ESWT) for erectile dysfunction Actinobaculum schaalii's role in urogenital infections Differential diagnosis of urological and surgical conditions Recent Research Trends: Her publications (2012–2020) emphasize minimally invasive urological procedures, microbial characterization of urogenital pathogens, and clinical evaluations of novel treatments. Key subfields include robotic surgery, infection management, health economics, and non-invasive therapeutic modalities. Collaborations: She works with multidisciplinary teams across Aalborg University Hospital and has co-authored studies with colleagues in urology, microbiology, and clinical research.

• Molecular Biology
• Genetics
• Genomics
• +۶ مورد دیگر

Eva Bang Harvald is a Teaching Associate Professor at the University of Southern Denmark, specializing in Functional Genomics & Metabolism. Her research spans molecular mechanisms in cardiomyocyte development, metabolism in C. elegans , and stem cell applications in metabolic disorders. Her work integrates transcriptomics for cardiac tissue analysis, autophagy studies in starvation response, and transcription factor mapping (e.g., ZEB1 in cardiomyocyte proliferation). She explores lipid metabolism and inflammatory pathways via Caenorhabditis elegans and biomedical translation. Recent publications focus on single-cell RNA sequencing in cardiomyocytes, stem cell therapy for diabetes-linked erectile dysfunction, and inflammasome signaling in autoimmune diseases. She received the 2024 NAT Teaching Prize and SDU Teaching Prize. NAT Teaching prize, SDU 2024 SDU Teaching prize, 2024 She teaches courses like BMB544 and BMB546, supervises MSc students, and participates in conferences including DUN Conference 2024 and Danish RNA Society Annual Meeting.

• Epidemiology
• Cancer Research
• Prostate Cancer
• +۴ مورد دیگر

Signe Liv Benzon Larsen serves as a Part-time Lecturer and External Lecturer in the Section of Epidemiology within the Department of Public Health at the University of Copenhagen's Faculty of Health and Medical Sciences. Her research focuses on cancer epidemiology with particular emphasis on prostate cancer outcomes. Education: MSc in Molecular Biology from Roskilde University (awarded January 23, 2009) Her research spans prostate cancer epidemiology, cancer survivorship, and comorbidities, with significant contributions to Nordic cancer registry studies. Key methodologies include population-based cohort analyses, survival statistics, and pharmacoepidemiology. Current work examines temporal trends in prostate cancer diagnosis, treatment patterns, and long-term health outcomes among cancer survivors. Recent publications demonstrate strong engagement with international collaborations, particularly through the NORDCAN project. Research has been featured in The Lancet Oncology , International Journal of Epidemiology , and other high-impact journals, with multiple studies receiving media coverage and social media attention. External Position: Group Leader at Copenhagen University Hospital - Rigshospitalet

• Urology
• Prostate Cancer
• Erectile Dysfunction
• +۳ مورد دیگر

Peter Busch Østergren serves as a Clinical Associate Professor in the Department of Clinical Medicine at the Faculty of Health and Medical Sciences, University of Copenhagen, with clinical affiliations in Urology at Region H (Capital Region of Denmark). His work bridges academic research and hospital-based clinical practice in Copenhagen. His research concentrates on urological oncology and men's health, specifically: Prostate cancer diagnostics, treatment outcomes, and exercise interventions for metastatic disease The cardiovascular implications of erectile dysfunction Testicular cancer screening methodologies and long-term risk assessment He employs advanced imaging techniques (MRI, PET/CT) and clinical trial frameworks to investigate patient outcomes. Analysis of his recent publications reveals a strong emphasis on translational urology research. His 2024-2025 output demonstrates consistent focus on prostate cancer management—from robotic surgery outcomes to bone metastasis imaging—and explores the critical link between erectile dysfunction and cardiac health. Methodologically, he favors prospective clinical trials and large-scale observational studies within Denmark's public healthcare system. No scientific awards were documented in the provided materials. While student advising details are absent from the source text, his collaborative publication pattern (33 total outputs) indicates active mentorship within multidisciplinary research teams. Grant involvement is implied through clinical trial protocols but not explicitly detailed. Dr. Østergren operates within Copenhagen's integrated academic-clinical ecosystem, collaborating extensively with Region H departments and university research units. His work shows particular alignment with prostate cancer research groups and cardiovascular-urology interdisciplinary initiatives.

Annamaria Giovanna Elena Giraldiمشاهده پروفایل

استاد بالینی

• Sexual Medicine
• Female Sexual Dysfunction
• Clinical Pharmacology
• +۳ مورد دیگر

Annamaria Giovanna Elena Giraldi is a Clinical Professor at the Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, and Consultant at the Sexological Clinic, Psychiatric Center Copenhagen, Rigshospitalet. Her dual clinical-academic role spans psychiatry, clinical pharmacology, and sexology, with extensive affiliations across Danish psychiatric institutions and international sexual medicine societies. Education: Medical Degree, University of Copenhagen (1993) Ph.D., University of Copenhagen (1997; thesis: cAMP and its involvement in signal transduction in erectile tissue) Research Interests: Giraldi's work centers on sexual medicine, with emphasis on female sexual dysfunction, diabetes-related sexual complications, pharmacological treatments, and psychiatric comorbidities. Her research bridges basic physiology (e.g., erectile tissue signaling) and clinical applications (e.g., drug trials for FSD), informed by her training in pharmacology, psychiatry, and sexology. She has pioneered studies on hormonal contraceptives' impact on sexual function and sexual health in chronic diseases. Publication Trends: Her 111+ publications (h-index 27) show consistent focus on sexual dysfunction classification, treatment guidelines, and women's sexual health. Recent work (2020-2025) addresses orgasmic disorders, bipolar disorder comorbidity, transgender fertility preservation, and prostate cancer survivorship, reflecting evolving priorities in sexual medicine toward interdisciplinary and patient-centered care. Honors: Jean Francois Ginestie Prize (2000, 2016) ISSWSH Fellow (2011) and European Committee of Sexual Medicine Fellow (2012) 2016 ISSM Female Sexual Dysfunction Prize Leadership roles in WHO consultations and ISSM standard committees Mentorship & Service: Giraldi has supervised 4 PhD students and numerous master's/bachelor projects. She served as Deputy Editor of the Journal of Sexual Medicine (2014-), chaired ISSM/ISSWSH committees, and advised pharmaceutical companies (Pfizer, Bayer). Her clinical work includes directing sexological trials (e.g., LAPIS A2181014 for FSD) and public health initiatives like the ED help line (2002-2006). Labs & Teams: She leads the Sexological Clinic at Rigshospitalet, collaborating with the Department of Biomedicine and international consortia like the European Society for Sexual Medicine. Her team includes researchers (e.g., Nanna Laesoe, Kristine Krakauer) and clinical staff focused on translational sexual medicine research.

• Oncology
• Cancer Survivorship
• Clinical Interventions
• +۴ مورد دیگر

Christoffer Johansen is a Clinical Professor at the University of Copenhagen's Department of Clinical Medicine, with offices at Blegdamsvej 9 (2100 København Ø) and Blegdamsvej 3 (2200 København N). His research focuses on clinical oncology, cancer survivorship, and patient-centered interventions. Contact: +4535257627 or christoffer.johansen@regionh.dk . Research Focus: Johansen's work spans multiple oncology domains with emphasis on: Cancer survivorship in aging populations Novel surveillance methods (e.g., ctDNA for melanoma) Quality-of-life interventions for prostate/breast cancer patients Behavioral strategies for recurrence fear management Publication Trends (2025): Recent articles demonstrate methodological diversity including randomized trials, population studies, and clinical protocol development. Dominant themes include survivorship care models, treatment side-effect management, and optimizing follow-up strategies across melanoma, lymphoma, and urologic cancers. Scientific Recognition: No awards mentioned in source material. Collaborations: International partnerships evident through Australian population studies and multi-country research consortia. No lab/team specifics provided.